Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
(Source: Abbott.com)
Source: Abbott.com - June 3, 2022 Category: Pharmaceuticals Source Type: news
HBCUs, Industry Partners Launch Initiative to Diversify and Strengthen Cybersecurity Workforce
(Source: Abbott.com)
Source: Abbott.com - June 2, 2022 Category: Pharmaceuticals Source Type: news
Abbott's FreeStyle Libre ® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
(Source: Abbott.com)
Source: Abbott.com - May 31, 2022 Category: Pharmaceuticals Source Type: news
Abbott to Release EleCare ® Amino Acid-based Formulas to Help Meet Critical Patient Need
(Source: Abbott.com)
Source: Abbott.com - May 24, 2022 Category: Pharmaceuticals Source Type: news
New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies
(Source: Abbott.com)
Source: Abbott.com - May 19, 2022 Category: Pharmaceuticals Source Type: news
Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility
(Source: Abbott.com)
Source: Abbott.com - May 16, 2022 Category: Pharmaceuticals Source Type: news
Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials
(Source: Abbott.com)
Source: Abbott.com - May 11, 2022 Category: Pharmaceuticals Source Type: news
Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
(Source: Abbott.com)
Source: Abbott.com - May 4, 2022 Category: Pharmaceuticals Source Type: news
Abbott to Release Metabolic Nutrition Formulas
(Source: Abbott.com)
Source: Abbott.com - April 29, 2022 Category: Pharmaceuticals Source Type: news
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
(Source: Abbott.com)
Source: Abbott.com - April 29, 2022 Category: Pharmaceuticals Source Type: news
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer ™ Steerable Delivery Sheath for the Company's Amulet™ Device
(Source: Abbott.com)
Source: Abbott.com - April 28, 2022 Category: Pharmaceuticals Source Type: news
New Analysis Shows that Abbott's FreeStyle Libre ® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes
(Source: Abbott.com)
Source: Abbott.com - April 28, 2022 Category: Pharmaceuticals Source Type: news
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes
(Source: Abbott.com)
Source: Abbott.com - April 27, 2022 Category: Pharmaceuticals Source Type: news
Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
(Source: Abbott.com)
Source: Abbott.com - April 26, 2022 Category: Pharmaceuticals Source Type: news
Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere ™ myPath™ Digital Health App
(Source: Abbott.com)
Source: Abbott.com - April 25, 2022 Category: Pharmaceuticals Source Type: news
